Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE

Load latest

Lasa Supergenerics Ltd.

24 Nov 2020

17.03

5.97%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Attached is the copy of Press Release titled 'Lasa Receives further Injunction from Hon'ble High Court, Bombay restraining its competitor from Manufacturing albendazole in addition to other reliefs which is subject matter of patent infringement case, until disposal of suit' issued by the company

pdf

Lasa Supergenerics Ltd.

04 Nov 2020

17.03

5.97%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Attached is a copy of Press Release tilted 'Lasa Supergenerics Receives Environmental Clearance for Benzimidazole Derivatives Capacity Expansion in Unit 2 Located at Khed'.

pdf

Lasa Supergenerics Ltd.

30 Oct 2020

17.03

5.97%

Company Update

Lasa Supergenerics Ltd - 540702 - HALF YEARLY CERTIFICATE FROM PRACTICING COMPANY SECRETARY UNDER REG 40(9)OF …

BSE India

Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the certificate from Amit R. Dadheech & Associates, Practicing Company Secretary for the half year ended September 30, 2020.

pdf

Lasa Supergenerics Ltd.

28 Oct 2020

17.03

5.97%

Investor Presentation

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

LASA Supergenerics October 2020 Investor Presentation 2020-2021.

pdf

Lasa Supergenerics Ltd.

27 Oct 2020

17.03

5.97%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Lasa Supergenerics Reports Revenue of ? 109 Crores in H1 FY21 higher by 38% YoY Profit After Tax in Q2 FY21 grew by 31% on a QoQ basis to ? 7 Crores.

pdf

Lasa Supergenerics Ltd.

26 Oct 2020

17.03

5.97%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Q2 FY21 Earning call will be represented by Dr Omkar Herlekar Chairman & Managing Director on Date: Thursday, 29th October 2020 Time: 12.00 Noon (IST).

pdf

Lasa Supergenerics Ltd.

26 Oct 2020

17.03

5.97%

Result

Lasa Supergenerics Ltd - 540702 - Outcome Of Board Meeting Held Today I.E. October 26, 2020

BSE India

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today through video conferencing which was commenced at 11.30 a.m. and concluded at 01:30 p.m. have considered, approved and took on record the Unaudited Financial Results for the quarter and Half year ended September 30 2020.

pdf

Lasa Supergenerics Ltd.

23 Oct 2020

17.03

5.97%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligation …

BSE India

This is to certify that in compliance with regulation 7(2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, all activities in relation to share transfer facility are maintained by our Share Transfer Agent i.e. Bigshare Services Private Limited having permanent SEBI Registration No INR0000001385.

pdf

Lasa Supergenerics Ltd.

21 Oct 2020, 05:58PM

17.03

5.97%

Company Update

Lasa Supergenerics Ltd - 540702 - Shareholding for the Period Ended September 30, 2020

BSE India

Lasa Supergenerics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here

Lasa Supergenerics Ltd.

21 Oct 2020, 04:15PM

17.03

5.97%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended September 30, 2020 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company.

pdf

Is Lasa Supergenerics Ltd. worth buying?

51 Votes:

Buy 76.47%

Sell 17.65%

Hold 5.88%

New 52W Low in past week

High volume+gain today

Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE